Last year, U.S. Navy Lt. Cmdr. Matthew Diaz was convicted of unlawfully disclosing classified information to an unauthorized person, after he provided the names of prisoners secretly held in military detention at Guantanamo Bay to a civil rights organization. He was sentenced to six months in prison and ordered discharged from the Navy.
Last week, Diaz was honored as a “truth teller” at the National Press Club in Washington, DC for the very same action.
He received the Ridenhour Award, named for the late Ron Ridenhour, who revealed the 1968 massacre of Vietnamese at My Lai.
“Lt. Cmdr. Diaz demonstrated independent judgment, fidelity to the Constitution, and uncommon courage,” according to the Ridenhour Award statement. “By disclosing the names of prisoners secretly detained at Guantanamo, he broke ranks and he violated the law, and for that he has paid a serious price. But we believe that he also demonstrated a profound loyalty to the United States and its enduring constitutional principles.”
The April 3 remarks of Matthew Diaz upon receiving the Ridenhour Award may be found here.
The award ceremony and some of the background to it were described by Joe Conason in “A Truth Teller Who Deserves Justice,” Salon.com, April 4.
A longer treatment of the Diaz case appeared in “Naming Names at Gitmo” by Tim Golden, New York Times Magazine, October 21, 2007.
Remarkably, Diaz appears to be the first American ever convicted under the espionage statutes for disclosing classified information to another American rather than to a foreign person or government, according to a new study of espionage in America.
Given the rapid pace of AI advancement, a proactive effort triumphs over a reactive one. To protect consumers, workers, and the economy more broadly, it is imperative that the FTC and DOJ adapt their enforcement strategies to meet the complexities of the AI era.
To encourage greater adoption of generic drugs in clinical practice the FDA should implement a dedicated regulatory pathway for non-manufacturers to seek approval of new indications for repurposed generic drugs.
The increasing frequency of extreme weather events, which caused over $200 billion in global economic losses in 2023, is disrupting global supply chains and exacerbating migration pressures, particularly for the U.S. Investing in climate resilience abroad offers a significant opportunity for U.S. businesses in technology, engineering, and infrastructure, while also supporting job creation at home.
Early-career and out-of-state teachers tend to be most heavily concentrated in Alaska’s rural schools, where they face a steep curve in adjusting to a new way of life while learning the ropes of teaching.